Cargando…
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VOCs) exhibit escape from neutralizing antibodies, causing concern about vaccine effectiveness. However, while non-neutralizing cytotoxic functions of antibodies are associated with improved disease outcome and vaccine...
Autores principales: | Richardson, Simone I., Manamela, Nelia P., Motsoeneng, Boitumelo M., Kaldine, Haajira, Ayres, Frances, Makhado, Zanele, Mennen, Mathilda, Skelem, Sango, Williams, Noleen, Sullivan, Nancy J., Misasi, John, Gray, Glenda G., Bekker, Linda-Gail, Ueckermann, Veronica, Rossouw, Theresa M., Boswell, Michael T., Ntusi, Ntobeko A.B., Burgers, Wendy A., Moore, Penny L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761540/ https://www.ncbi.nlm.nih.gov/pubmed/35233544 http://dx.doi.org/10.1016/j.xcrm.2022.100510 |
Ejemplares similares
-
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern
por: Kitchin, Dale, et al.
Publicado: (2022) -
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
por: Motsoeneng, Boitumelo M., et al.
Publicado: (2023) -
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2023) -
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2023) -
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)